Medtronic is sponsoring the SMART randomized head-to-head trial comparing its Evolut PRO and Evolut PRO+ self-expanding transcatheter aortic valve replacement systems against Edwards Lifesciences’ Sapien 3 and Sapien 3 Ultra balloon-expandable TAVR systems in patients with severe symptomatic aortic stenosis.
The Small Annuli Randomized To Evolut or Sapien (SMART) trial will enroll about 700 patients with small aortic annuli and patients with a failed surgical aortic valve – the so-called...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?